<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC11506346</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC11506346.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">11506346</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">11506346</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">39451989</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.3390/brainsci14100975</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">brainsci-14-00975</article-id></all-ids><extracted-table><table-id>brainsci-14-00975-t001</table-id><table-label>Table 1</table-label><table-caption>Demographic characteristics of healthy controls and pwMS.</table-caption><table-wrap-foot>EDSS: Expanded Disability Status Scale; HCs: healthy controls; MS: multiple sclerosis; MS-no-LUTS: MS patients without lower urinary tract symptoms; MS-OAB: MS patients with OAB; N/A: not applicable; OAB: overactive bladder; pwMS: patients with MS; USP: Urinary Symptom Profile; USP-OAB: USP OAB sub-score. Statistically significant difference was found between HCs and pwMS. MS-no-LUTS and MS-OAB were tested using Chi Square test, student’s t-test, and Mann–Whitney U test. a: statistical difference between HCs and pwMS; b: statistical difference between MS-no-LUTS and MS-OAB. *: p &lt; 0.05; **: p &lt; 0.01.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="brainsci-14-00975-t001" orientation="portrait"><object-id pub-id-type="pii">brainsci-14-00975-t001_Table 1</object-id><label>Table 1</label><caption><p>Demographic characteristics of healthy controls and pwMS.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"/><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HCs</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">pwMS</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MS-no-LUTS</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MS-OAB</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">n</td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">N/A <sup>b</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Mean age, years (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">48.5 (20.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">43.3 (9.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">37.5 (8.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">46.1 (8.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.641 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.026 <sup>b,</sup>*</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Mean EDSS (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3 (1.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9 (0.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.9 (2.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.004 <sup>b,</sup>**</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Median lesion volume, ×10<sup>3</sup> mL (range)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">7.7 (0.2–69.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.9 (0.2–13.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.8 (1.0–69.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.055 <sup>b,</sup>*</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Median disease duration, years (range)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">10.0 (0.8–42.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0 (1.0–14.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.3 (0.8–42.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.029 <sup>b,</sup>*</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean USP-OAB (SD)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1 (1.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.9 (4.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0 (1.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.8 (3.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.001 <sup>a,</sup>**</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.001 <sup>b,</sup>**</td></tr></tbody></table><table-wrap-foot><fn><p>EDSS: Expanded Disability Status Scale; HCs: healthy controls; MS: multiple sclerosis; MS-no-LUTS: MS patients without lower urinary tract symptoms; MS-OAB: MS patients with OAB; N/A: not applicable; OAB: overactive bladder; pwMS: patients with MS; USP: Urinary Symptom Profile; USP-OAB: USP OAB sub-score. Statistically significant difference was found between HCs and pwMS. MS-no-LUTS and MS-OAB were tested using Chi Square test, student’s <italic toggle="yes">t</italic>-test, and Mann–Whitney U test. <sup>a</sup>: statistical difference between HCs and pwMS; <sup>b</sup>: statistical difference between MS-no-LUTS and MS-OAB. *: <italic toggle="yes">p</italic> &lt; 0.05; **: <italic toggle="yes">p</italic> &lt; 0.01.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>brainsci-14-00975-t001_Table 1Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic characteristics of healthy controls and pwMS.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"/><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">HCs</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">pwMS</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">MS-no-LUTS</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">MS-OAB</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">p-Value</th></tr></thead><tbody><tr><td align="left" valign="middle">n</td><td align="center" valign="middle">14</td><td align="center" valign="middle">29</td><td align="center" valign="middle">9</td><td align="center" valign="middle">17</td><td align="center" valign="middle">N/A a</td><td align="center" valign="middle">N/A b</td></tr><tr><td align="left" valign="middle">Mean age, years (SD)</td><td align="center" valign="middle">48.5 (20.0)</td><td align="center" valign="middle">43.3 (9.4)</td><td align="center" valign="middle">37.5 (8.9)</td><td align="center" valign="middle">46.1 (8.6)</td><td align="center" valign="middle">0.641 a</td><td align="center" valign="middle">0.026 b,*</td></tr><tr><td align="left" valign="middle">Mean EDSS (SD)</td><td align="center" valign="middle">N/A</td><td align="center" valign="middle">2.3 (1.8)</td><td align="center" valign="middle">0.9 (0.9)</td><td align="center" valign="middle">2.9 (2.0)</td><td align="center" valign="middle">N/A a</td><td align="center" valign="middle">0.004 b,**</td></tr><tr><td align="left" valign="middle">Median lesion volume, ×103 mL (range)</td><td align="center" valign="middle">N/A</td><td align="center" valign="middle">7.7 (0.2–69.6)</td><td align="center" valign="middle">1.9 (0.2–13.7)</td><td align="center" valign="middle">8.8 (1.0–69.6)</td><td align="center" valign="middle">N/A a</td><td align="center" valign="middle">0.055 b,*</td></tr><tr><td align="left" valign="middle">Median disease duration, years (range)</td><td align="center" valign="middle">N/A</td><td align="center" valign="middle">10.0 (0.8–42.0)</td><td align="center" valign="middle">4.0 (1.0–14.0)</td><td align="center" valign="middle">12.3 (0.8–42.0)</td><td align="center" valign="middle">N/A a</td><td align="center" valign="middle">0.029 b,*</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin">Mean USP-OAB (SD)</td><td align="center" valign="middle" style="border-bottom:solid thin">1.1 (1.7)</td><td align="center" valign="middle" style="border-bottom:solid thin">5.9 (4.7)</td><td align="center" valign="middle" style="border-bottom:solid thin">1.0 (1.0)</td><td align="center" valign="middle" style="border-bottom:solid thin">8.8 (3.7)</td><td align="center" valign="middle" style="border-bottom:solid thin">&lt;0.001 a,**</td><td align="center" valign="middle" style="border-bottom:solid thin">&lt;0.001 b,**</td></tr></tbody></table></div>EDSS: Expanded Disability Status Scale; HCs: healthy controls; MS: multiple sclerosis; MS-no-LUTS: MS patients without lower urinary tract symptoms; MS-OAB: MS patients with OAB; N/A: not applicable; OAB: overactive bladder; pwMS: patients with MS; USP: Urinary Symptom Profile; USP-OAB: USP OAB sub-score. Statistically significant difference was found between HCs and pwMS. MS-no-LUTS and MS-OAB were tested using Chi Square test, student’s t-test, and Mann–Whitney U test. a: statistical difference between HCs and pwMS; b: statistical difference between MS-no-LUTS and MS-OAB. *: p &lt; 0.05; **: p &lt; 0.01.</transformed-table></extracted-table><extracted-table><table-id>brainsci-14-00975-t002</table-id><table-label>Table 2</table-label><table-caption>FA values of mean skeleton in HCs, pwMS, and pwMS sub-groups.</table-caption><table-wrap-foot>FA: fractional anisotropy; HCs: healthy controls; MS: multiple sclerosis; MS-no-LUTS: MS patients without lower urinary tract symptoms; MS-OAB: MS patients with OAB; N/A: not applicable; pwMS: patients with MS. Statistically significant difference was found between HCs and pwMS. MS-no-LUTS and MS-OAB were tested using Mann–Whitney U test. *: p &lt; 0.05; **: p &lt; 0.01.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="brainsci-14-00975-t002" orientation="portrait"><object-id pub-id-type="pii">brainsci-14-00975-t002_Table 2</object-id><label>Table 2</label><caption><p>FA values of mean skeleton in HCs, pwMS, and pwMS sub-groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"/><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">FA of Mean Skeleton<break/>(Median, Range)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value<break/>(Adjusted for Age)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value<break/>(Adjusted for EDSS)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value<break/>(Adjusted for Age + EDSS)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">HCs (n = 14)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4590268<break/>(0.4404533, 0.4853403)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.004 **</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">N/A</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">N/A</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pwMS (n = 29)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4338049<break/>(0.3303200, 0.4874299)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MS-no-LUTS (n = 9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4446728<break/>(0.4288627, 0.4740112)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.159</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.047 *</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.072</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS-OAB (n = 17)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4299469<break/>(0.3305743, 0.4859033)</td></tr></tbody></table><table-wrap-foot><fn><p>FA: fractional anisotropy; HCs: healthy controls; MS: multiple sclerosis; MS-no-LUTS: MS patients without lower urinary tract symptoms; MS-OAB: MS patients with OAB; N/A: not applicable; pwMS: patients with MS. Statistically significant difference was found between HCs and pwMS. MS-no-LUTS and MS-OAB were tested using Mann–Whitney U test. *: <italic toggle="yes">p</italic> &lt; 0.05; **: <italic toggle="yes">p</italic> &lt; 0.01.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>brainsci-14-00975-t002_Table 2Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">FA values of mean skeleton in HCs, pwMS, and pwMS sub-groups.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"/><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">FA of Mean Skeleton(Median, Range)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">p-Value(Adjusted for Age)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">p-Value(Adjusted for EDSS)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">p-Value(Adjusted for Age + EDSS)</th></tr></thead><tbody><tr><td align="left" valign="middle">HCs (n = 14)</td><td align="center" valign="middle">0.4590268(0.4404533, 0.4853403)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin">0.004 **</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin">N/A</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin">N/A</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin">pwMS (n = 29)</td><td align="center" valign="middle" style="border-bottom:solid thin">0.4338049(0.3303200, 0.4874299)</td></tr><tr><td align="left" valign="middle">MS-no-LUTS (n = 9)</td><td align="center" valign="middle">0.4446728(0.4288627, 0.4740112)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin">0.159</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin">0.047 *</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin">0.072</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin">MS-OAB (n = 17)</td><td align="center" valign="middle" style="border-bottom:solid thin">0.4299469(0.3305743, 0.4859033)</td></tr></tbody></table></div>FA: fractional anisotropy; HCs: healthy controls; MS: multiple sclerosis; MS-no-LUTS: MS patients without lower urinary tract symptoms; MS-OAB: MS patients with OAB; N/A: not applicable; pwMS: patients with MS. Statistically significant difference was found between HCs and pwMS. MS-no-LUTS and MS-OAB were tested using Mann–Whitney U test. *: p &lt; 0.05; **: p &lt; 0.01.</transformed-table></extracted-table><extracted-table><table-id>brainsci-14-00975-t003</table-id><table-label>Table 3</table-label><table-caption>Correlations between FA values and clinical scores.</table-caption><table-wrap-foot>Spearman’s correlations between FA value and age; EDSS and USP-OAB sub-score were tested in HCs and pwMS. EDSS: Expanded Disability Status Scale; FA: fractional anisotropy; MS: multiple sclerosis; N/A: not applicable; p: p-value of correlation; pwMS: patients with MS; r: Spearman’s correlation coefficient (two-tailed); USP-OAB: Urinary Symptom Profile OAB sub-score. *: p &lt; 0.05; **: p &lt; 0.01.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="brainsci-14-00975-t003" orientation="portrait"><object-id pub-id-type="pii">brainsci-14-00975-t003_Table 3</object-id><label>Table 3</label><caption><p>Correlations between FA values and clinical scores.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"/><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EDSS</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">USP-OAB</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FA of mean skeleton of all subjects (n = 43)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r = −0.36 *<break/><italic toggle="yes">p</italic> = 0.018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r = −0.493 **<break/><italic toggle="yes">p</italic> = 0.001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FA of mean skeleton of pwMS (n = 26)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r = −0.51 **<break/><italic toggle="yes">p</italic> = 0.008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r = −0.271<break/><italic toggle="yes">p</italic> = 0.181</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r = −0.449 *<break/><italic toggle="yes">p</italic> = 0.021</td></tr></tbody></table><table-wrap-foot><fn><p>Spearman’s correlations between FA value and age; EDSS and USP-OAB sub-score were tested in HCs and pwMS. EDSS: Expanded Disability Status Scale; FA: fractional anisotropy; MS: multiple sclerosis; N/A: not applicable; <italic toggle="yes">p</italic>: <italic toggle="yes">p</italic>-value of correlation; pwMS: patients with MS; r: Spearman’s correlation coefficient (two-tailed); USP-OAB: Urinary Symptom Profile OAB sub-score. *: <italic toggle="yes">p</italic> &lt; 0.05; **: <italic toggle="yes">p</italic> &lt; 0.01.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>brainsci-14-00975-t003_Table 3Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Correlations between FA values and clinical scores.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"/><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">EDSS</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">USP-OAB</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin">FA of mean skeleton of all subjects (n = 43)</td><td align="center" valign="middle" style="border-bottom:solid thin">r = −0.36 *p = 0.018</td><td align="center" valign="middle" style="border-bottom:solid thin">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin">r = −0.493 **p = 0.001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin">FA of mean skeleton of pwMS (n = 26)</td><td align="center" valign="middle" style="border-bottom:solid thin">r = −0.51 **p = 0.008</td><td align="center" valign="middle" style="border-bottom:solid thin">r = −0.271p = 0.181</td><td align="center" valign="middle" style="border-bottom:solid thin">r = −0.449 *p = 0.021</td></tr></tbody></table></div>Spearman’s correlations between FA value and age; EDSS and USP-OAB sub-score were tested in HCs and pwMS. EDSS: Expanded Disability Status Scale; FA: fractional anisotropy; MS: multiple sclerosis; N/A: not applicable; p: p-value of correlation; pwMS: patients with MS; r: Spearman’s correlation coefficient (two-tailed); USP-OAB: Urinary Symptom Profile OAB sub-score. *: p &lt; 0.05; **: p &lt; 0.01.</transformed-table></extracted-table></extracted-tables-set>